CancerFree Biotech
PrivateLast Round
Grant
May 6, 2025
Total Funding Raised
$1.18M
Company Overview
CancerFree Biotech operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Grant round in May 2025.
CancerFree Biotech is a biotechnology company that provides a circulating tumor cell-derived organoid platform designed to predict patient responses to cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CancerFree Biotech Comparables
Compare CancerFree Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pear Bio | 79% | |
| OnconiX AG | 78% | |
| Orakl Oncology | 77% |
For institutional investors. Book with your work email.
CancerFree Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 6, 2025 | ||||
| Accelerator | Apr 25, 2025 | ||||
| Accelerator | Jul 1, 2023 | ||||
| Seed | Nov 28, 2022 | ||||
| Accelerator | Sep 28, 2021 | ||||
Grant | Aug 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CancerFree Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taipei City Government | Grant |
| Berkeley SkyDeck | Accelerator |
| SIC Sustainable Impact Capital | Seed |
| Sustainable Impact Capital | Seed |
| Okinawa Prefectural Government | Accelerator |
| Draper Associates | Seed |
| Taipei Medical University | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 88% MoM, reaching 3.2K.
- Mar 1, 2026
Monthly visitors increased 67% MoM.
For institutional investors. Book with your work email.
CancerFree Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CancerFree Biotech's valuation, stock price, and market status.
Is CancerFree Biotech a public or private company?
CancerFree Biotech is a private company.
What is the current stock price of CancerFree Biotech?
CancerFree Biotech is a private company, so its shares have no public market price. Caplight tracks CancerFree Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CancerFree Biotech worth (valuation)?
Valuation information for CancerFree Biotech is not publicly available.
Can I buy CancerFree Biotech stock?
CancerFree Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CancerFree Biotech's last funding round?
CancerFree Biotech's most recent funding round was Grant on May 6, 2025.
Who are the main investors in CancerFree Biotech?
Key investors in CancerFree Biotech include Taipei City Government, Berkeley SkyDeck, SIC Sustainable Impact Capital, Sustainable Impact Capital, Okinawa Prefectural Government.
Will CancerFree Biotech IPO soon?
No public IPO plans have been announced for CancerFree Biotech.
How can I track CancerFree Biotech secondary market activity?
Caplight tracks bids, offers, and trades in CancerFree Biotech's shares on secondary markets.